Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Jan;52(1):14–20. doi: 10.1136/ard.52.1.14

Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology.

M Okamura 1, Y Kanayama 1, K Amastu 1, N Negoro 1, S Kohda 1, T Takeda 1, T Inoue 1
PMCID: PMC1004949  PMID: 8427508

Abstract

The correlation between renal histology and class specific (IgG and IgM) antibodies to double stranded DNA (dsDNA) and single stranded DNA (ssDNA) was studied by enzyme linked immunosorbent assay (ELISA) in 40 untreated patients with systemic lupus erythematosus (SLE). The levels of IgG antibodies to dsDNA were significantly higher in patients with World Health Organisation class IV nephritis than in those with class I, class II, or class III nephritis. IgG antibodies to ssDNA were higher in patients with class IV than in those with class II nephritis. IgG antibodies to dsDNA showed a close correlation with the histological activity score and the amount of electron dense deposit. IgG antibodies to ssDNA showed only a weak correlation with the renal histological activity score. IgM antibodies to dsDNA and IgM antibodies to ssDNA were not correlated with renal histological features. Patients with moderate to severe nephritis had a lower ratio of IgM antibodies to dsDNA to IgG antibodies to dsDNA than those with mild nephritis. These results indicate that the measurement of IgG antibodies to dsDNA is predictive in evaluating renal histological activity in patients with SLE.

Full text

PDF
14

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andres G. A., Accinni L., Beiser S. M., Christian C. L., Cinotti G. A., Erlanger B. F., Hsu K. C., Seegal B. C. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis. J Clin Invest. 1970 Nov;49(11):2106–2118. doi: 10.1172/JCI106428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Appel A. E., Sablay L. B., Golden R. A., Barland P., Grayzel A. I., Bank N. The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study. Am J Med. 1978 Feb;64(2):274–283. doi: 10.1016/0002-9343(78)90056-6. [DOI] [PubMed] [Google Scholar]
  3. Austin H. A., 3rd, Muenz L. R., Joyce K. M., Antonovych T. T., Balow J. E. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984 Apr;25(4):689–695. doi: 10.1038/ki.1984.75. [DOI] [PubMed] [Google Scholar]
  4. Ballou S. P., Kushner I. Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus. Clin Exp Immunol. 1979 Jul;37(1):58–67. [PMC free article] [PubMed] [Google Scholar]
  5. Beaulieu A., Quismorio F. P., Jr, kitridou R. C., Friou G. J. Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method. J Rheumatol. 1979 Jul-Aug;6(4):389–396. [PubMed] [Google Scholar]
  6. Chubick A., Sontheimer R. D., Gilliam J. N., Ziff M. An appraisal of tests for native DNA antibodies in connective tissue diseases. Clinical usefulness of Crithidia luciliae assay. Ann Intern Med. 1978 Aug;89(2):186–192. doi: 10.7326/0003-4819-89-2-186. [DOI] [PubMed] [Google Scholar]
  7. Clough J. D., Valenzuela R. Relationship of renal histopathology in SLE nephritis to immunoglobulin class of anti-DNA. Am J Med. 1980 Jan;68(1):80–85. doi: 10.1016/0002-9343(80)90169-2. [DOI] [PubMed] [Google Scholar]
  8. Edmonds J. P., Johnson G. D., Ansell B. M., Holborow E. J. The value of tests for antibodies to DNA in monitoring the clinical course of SLE. A long-term study using the Farr test and the DNA counterimmunoelectrophoretic method. Clin Exp Immunol. 1975 Oct;22(1):9–15. [PMC free article] [PubMed] [Google Scholar]
  9. Eiser A. R., Katz S. M., Swartz C. Clinically occult diffuse proliferative lupus nephritis. An age-related phenomenon. Arch Intern Med. 1979 Sep;139(9):1022–1025. [PubMed] [Google Scholar]
  10. Feldman M. D., Huston D. P., Karsh J., Balow J. E., Klima E., Steinberg A. D. Correlation of serum IgG, IgM, and anti-native-DNA antibodies with renal and clinical indexes of activity in systemic lupus erythematosus. J Rheumatol. 1982 Jan-Feb;9(1):52–58. [PubMed] [Google Scholar]
  11. Gilliam A. C., Lang D., LoSpalluto J. J. Antibodies to double-stranded DNA: purification and characterization of binding specificities. J Immunol. 1980 Aug;125(2):874–885. [PubMed] [Google Scholar]
  12. Gripenberg M., Linder E., Kurki P., Engvall E. A solid phase enzyme-linked immunosurbent assay (ELISA) for the demonstration of antibodies against denatured, single-stranded DNA in patient sera. Scand J Immunol. 1978;7(2):151–157. doi: 10.1111/j.1365-3083.1978.tb00438.x. [DOI] [PubMed] [Google Scholar]
  13. Grishman E., Porush J. G., Lee S. L., Churg J. Renal biopsies in lupus nephritis. Correlation of electron microscopic findings with clinical course. Nephron. 1973;10(1):25–36. doi: 10.1159/000180175. [DOI] [PubMed] [Google Scholar]
  14. Hill G. S., Hinglais N., Tron F., Bach J. F. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med. 1978 Jan;64(1):61–79. doi: 10.1016/0002-9343(78)90180-8. [DOI] [PubMed] [Google Scholar]
  15. Hughes G. R., Cohen S. A., Christian C. L. Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis. 1971 May;30(3):259–264. doi: 10.1136/ard.30.3.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Klotz J. L., Minami R. M., Teplitz R. L. An enzyme-linked immunosorbent assay for antibodies to native and denatured DNA. J Immunol Methods. 1979;29(2):155–165. doi: 10.1016/0022-1759(79)90065-6. [DOI] [PubMed] [Google Scholar]
  17. Koffler D., Agnello V., Kimkel H. G. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am J Pathol. 1974 Jan;74(1):109–124. [PMC free article] [PubMed] [Google Scholar]
  18. Koffler D., Agnello V., Winchester R., Kunkel H. G. The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest. 1973 Jan;52(1):198–204. doi: 10.1172/JCI107165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Leon S. A., Green A., Ehrlich G. E., Poland M., Shapiro B. Avidity of antibodies in SLE: relation to severity of renal involvement. Arthritis Rheum. 1977 Jan-Feb;20(1):23–29. doi: 10.1002/art.1780200104. [DOI] [PubMed] [Google Scholar]
  20. Mahajan S. K., Ordóez N. G., Feitelson P. J., Lim V. S., Spargo B. H., Katz A. I. Lupus nephropathy without clinical renal involvement. Medicine (Baltimore) 1977 Nov;56(6):493–501. doi: 10.1097/00005792-197711000-00004. [DOI] [PubMed] [Google Scholar]
  21. Miller T. E., Lahita R. G., Zarro V. J., MacWilliam J., Koffler D. Clinical significance of anti-double-stranded DNA antibodies detected by a solid phase enzyme immunoassay. Arthritis Rheum. 1981 Apr;24(4):602–610. doi: 10.1002/art.1780240406. [DOI] [PubMed] [Google Scholar]
  22. Pennebaker J. B., Gilliam J. N., Ziff M. Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus. J Clin Invest. 1977 Dec;60(6):1331–1338. doi: 10.1172/JCI108892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rubin R. L., Joslin F. G., Tan E. M. An improved ELISA for anti-native DNA by elimination of interference by anti-histone antibodies. J Immunol Methods. 1983 Oct 28;63(3):359–366. doi: 10.1016/s0022-1759(83)80009-x. [DOI] [PubMed] [Google Scholar]
  24. Sontheimer R. D., Gilliam J. N. An immunofluorescence assay for double-stranded DNA antibodies using the Crithidia luciliae kinetoplast as a double-stranded DNA substrate. J Lab Clin Med. 1978 Apr;91(4):550–558. [PubMed] [Google Scholar]
  25. Steinman C. R., Deesomchok U., Spiera H. Detection of anti-DNA antibody using synthetic antigens. Characterization and clinical significance of binding of poly (deoxyadenylate-deoxythymidylate) by serum. J Clin Invest. 1976 May;57(5):1330–1341. doi: 10.1172/JCI108401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Steinman C. R., Grishman E., Spiera H., Deesomochok U. Binding of synthetic double-stranded DNA by serum from patients with systemic lupus erythematosus: correlation with renal histology. Am J Med. 1977 Mar;62(3):319–323. doi: 10.1016/0002-9343(77)90827-0. [DOI] [PubMed] [Google Scholar]
  27. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  28. Tron F., Bach J. F. Relationships between antibodies to native DNA and glomerulonephritis in systemic lupus erythematosus. Clin Exp Immunol. 1977 Jun;28(3):426–432. [PMC free article] [PubMed] [Google Scholar]
  29. Winfield J. B., Faiferman I., Koffler D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J Clin Invest. 1977 Jan;59(1):90–96. doi: 10.1172/JCI108626. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES